Clinical Trial Update: Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating daily tadalafil for gastric emptying in diabetic gastroparesis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis
• Gastroparesis

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Mark Feinglos | Conditions: Gastroparesis, Diabetic Gastroparesis | Phase 4 | Status: WITHDRAWN